← All trials
NCT04966234
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 22, 2021
- Primary completion
- Apr 30, 2023
- Completion date
- Nov 30, 2023
- First posted
- Jul 19, 2021
- Last posted
- Jul 19, 2021
- Enrollment
- 135
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Bambino Gesù Hospital and Research InstituteLead sponsor
- Radboud UniversityCollaborator
- University of ExeterStudy director
- University of ExeterCollaborator
- Consorzio per Valutazioni Biologiche e FarmacologicheCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.